TO EVALUATE THE SERUM ASCORBIC ACID LEVELS IN FRESH MYOCARDIAL INFRACTION PATIENTS AND TO COMPARE THEM WITH NORMAL HEALTHY INDIVIDUALS

NAVDEEP KAUR; JASPREET KAUR; JASWANT KAUR

doi:10.22159/ajpcr.2023.v16i4.47038

Authors

NAVDEEP KAUR Department of Biochemistry, Acharya Shri Chander College of Medical Sciences and Hospital, Jammu, Jammu and Kashmir, India.
JASPREET KAUR Department of Biochemistry, Noida International Institute of Medical Sciences, Gautam Buddha Nagar, Uttar Pradesh, India.
JASWANT KAUR Department of Biochemistry, NC Medical College and Hospital, Panipat, Haryana, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i4.47038

Keywords:

Ascorbic acid, Lipid profiles, Myocardial infarction

Abstract

Objective: Decreased serum magnesium and ascorbic acid has been associated with increased risk of myocardial infarction (MI). The present study was planned to evaluate the status of ascorbic acid in patients suffering from MI and to compare them with normal healthy individuals.

Methods: This retrospective study was conducted in the Department of Biochemistry in collaboration with the Department of Medicine, Government Medical College, Guru Nanak Dev Hospital, Amritsar. Fifty patients already diagnosed with MI, attending medicine OPD and IPD. Fifty healthy individuals with ages and sex-matched from the same population served as controls. Plasma acorbic acid levels and lipid profiles were also estimated.

Result: In our study, we observed that the difference between the plasma ascorbic acid levels of normal individuals and the patient of MI was statistically highly significant (p<0.001). It was also seen that the maximum number of subjects was found the age of 51–70 years in MI patients.

Conclusion: Decreased plasma ascorbic acid levels may be one of the causes of MI, so its supplementation may delay MI and its complications.

Downloads

Download data is not yet available.

References

Morrow DA, Braunwald E. Classification and diagnosis of acute coronary syndromes. In: Morrow DA, editor. Myocardial Infarction: A Companion to Braunwald’s Heart Disease. Netherlands: Elsevier; 2016. p. 1-10.

Chen L, Sun X, Wang Z, Lu Y, Chen M, He Y, et al. The impact of plasma vitamin C levels on the risk of cardiovascular diseases and Alzheimer’s disease: A Mendelian randomization study. Clin Nutr 2021;40:5327-34. doi: 10.1016/j.clnu.2021.08.020, PMID 34537655

Rasmussen HS, Aurup P, Goldstein K, Nair PM, Mortensen PB, Larsen OG, et al. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double blind, placebo controlled study. Archintern Med 1989;149:1050-3.

Jialal I, Fuller CJ. Oxidatively modified LDL and atherosclerosis: An evolving plausible scenario. Crit Rev Food Sci Nutr 1996;36:341-55. doi: 10.1080/10408399609527729, PMID 8740438

Ashor AW, Lara J, Mathers JC, Siervo M. Effect of vitamin C on endothelial function in health and disease: A systematic review and meta-analysis of randomised controlled trials. Atherosclerosis 2014;235:9-20. doi: 10.1016/j.atherosclerosis.2014.04.004, PMID 24792921

Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54 (6 Suppl:1113S-8. doi: 10.1093/ajcn/54.6.1113s, PMID 1962556

Retsky KL, Frei B. Vitamin C prevents metal ion dependent initiation and propagation of lipid peroxidation in human low density lipoprotein. Biochim Biophys Acta 1995;1257:279-87. doi: 10.1016/0005- 2760(95)00089-u, PMID 7647104

Simon JA. Vitamin C and cardiovascular disease: A review. J Am Coll Nutr 1992;11:107-25. doi: 10.1080/07315724.1992.12098232, PMID 1578086

Jacques PF, Sulsky SI, Perrone GA, Schaefer EJ. Ascorbic acid and plasma lipids. Epidemiology 1994;5:19-26. doi: 10.1097/00001648- 199401000-00005, PMID 8117777

Quamhich HT, Flack JM, Hilner JE, Howard BV, Tracy RP. Plasma fibrinogen levels and correlates in young adults. Am J Epidemiol 1993;138:1023-36.

Grundy SM. Cholesterol and MI. Arch Intern Med 1997;157:1177-84. doi: 10.1001/archinte.157.11.1177, PMID 9183228

Austin MA. Plasma triglycerides and coronary heart disease. Arterioscler Thromb 1991;111:2-14. doi: 10.1161/01.atv.11.1.2, PMID 1987999

Heyden S, Heiss G, Hames CG, Bartel AG. Fasting triglycerides as predictor of total and MI mortality in Evan country Georgia. J Chronic Dis 1980;33:275-82. doi: 10.1016/0021-9681(80)90022-3, PMID 7372765

Simuans LA. Triglyceride levels and the risk of MI: A view from Australia. Am J Cardiol 1992;70:144-84.

Carlson LA, Bottiger LE. Hypertriglyceridemia in occlusive MI. Atherosclerosis 1981;392:37-8.

Simon JA, Murtaugh MA, Gross MD, Loria CM, Hulley SB, Jacobs DR. Relation of ascorbic acid to coronary artery calcium: The coronary artery risk development in young adults study. Am J Epidemiol 2004;159:581-8. doi: 10.1093/aje/kwh079, PMID 15003962

Libby P. The concept of atherosclerotic risk factors. In: Harrison’s Principles of Internal Medicine. 16th ed., Vol. 02. New York: McGraw Hills; 2005. p. 1425-33.